Table 3 .
Breast cancer liver metastases status for ablation group
| Study | Total no. of patients | Single metastases (%) | Synchronous metastases (%) | Mean age at hepatectomy ± sd | Total no. of metastases | Complete ablation (on total no. of metastases) | Incomplete ablation (on total no. of metastases) | Receptor status (%) | Extrahepatic disease (%) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ER + | PR + | HER + | |||||||||
| Bai46 | 69 | 35 (51) | 3 (4) | 50.3±10 | 135 | 125 (93) | 10 (7) | 43(62) | 37 (54) | 22 (32) | 32 (46) |
| Onal47 | 22 | 19 (86) | 3 (14) | – | 29 | – | – | 17 (77) | 13 (59) | – | 15 (48) |
| Abbas20 | 11 | 5 (45) | 3 (27) | 54 | – | – | – | 5 (63) | 2 (25) | 1 (14) | 4 (36) |
| Veltri48 | 45 | 27 (60) | 6 (13) | 45±8 | 87 | 78 (90) | 9 (10) | – | – | – | 18 (40) |
| Taşçi49 | 24 | – | – | 50±2 | 57 | – | – | 6 (25) | 4 (16) | 6 (25) | – |
| Polistina30 | 14 | 1 (7) | – | 56±13 | 54 | 51 (94) | 3 (6) | 11 (78) | 8 (57) | 3 (21) | – |
| Carrafiello50 | 13 | 8 (61) | – | 54±13 | 21 | 21 (100) | 0 (0) | – | – | – | 8 (61) |
| Meloni51 | 52 | – | 8 (15) | 55±14 | 87 | 83 (95) | 4 (5) | – | – | – | 27 (52) |
| Jakobs52 | 43 | – | 27 (32) | 57±8 | 111 | 107 (96) | 4 (4) | 18 (42) | 18 (42) | 11 (25) | 18 (42) |
| Sofocleous53 | 12 | – | – | 55±7 | 14 | 13 (92) | 1 (8) | 3 (25) | 2 (16) | 6 (50) | 10 (83) |